Antineutrophil cytoplasmic antibody-associated vasculitis and chronic lymphocytic leukemia: A rare association
Editor, Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is a chronic lymphoproliferative disorder and has the propensity to develop autoantibodies against any cell lineage of bone marrow, commonly present as autoimmune hemolytic anemia and thrombocytopenia. [1] Rarely, it can induce autoantibodies against neutrophils which may manifest as crescentic glomerulonephritis. We report here a female patient with CLL and vasculitis related to antineutrophil cytoplasmic antibodies (ANCAs) presenting with rapidly progressive glomerulonephritis.
A 40-year-old female presented with progressive cervical lymphadenopathy with fever and night sweats of 1-month duration. The evaluation revealed total leukocyte count of 59,000/ cumm and smudge cells in peripheral smear. Immunophenotyping of bone marrow showed CD5, CD19, CD23 positive and CD10, CD20, CD79b, CD38, and Zap-70 negative B-cell clone in 85% of bone marrow leukocytes. She was diagnosed to have CLL-Rai stage 1. She was started on chemotherapy with intravenous (IV) cyclophosphamide with prednisolone 1 mg/kg/day along with IV bendamustine 100 mg IV for 2 days in a month. She was under remission for the next 1 year after which she developed oliguric renal failure. Laboratory investigations revealed urine analysis: 3+ proteinuria with 5-6 red blood cells/hpf; urine protein creatinine ratio: 4.5; blood hemoglobin: 6.2 g/dl; total leukocyte count: 23,200 cells/m 3 ; differential count: polymorph 38% and lymphocytes 62%; platelet count: 3.2 lakhs/cumm; blood urea: 119 mg/dl; serum creatinine: 6 mg/dl; serum uric acid: 8.4 mg/ dl; corrected serum calcium: 7.5 mg/dl; serum phosphorus: 5.9 mg/dl; serum sodium: 135 meq/l; potassium: 4.1 meq/l; and serum lactate dehydrogenase: 242 U/l. Viral markers (hepatitis B surface antigen, anti-hepatitis C virus, and HIV) were negative. Antinuclear antibodies and dsDNA were negative. Serum complements C3 (97.5 mg/dl) and C4 (24.4 mg/dl) were normal. c-ANCA (anti-PR-3) was positive by indirect IF and ELISA. Ultrasound examination revealed renomegaly. Renal biopsy showed segmental necrosis [ Figure 1 ] of capillary tuft in 5 out of 13 glomeruli, with cellular crescents in 6 glomeruli. Dense inflammatory infiltrates throughout the core and sheets of lymphocytes in renal capsular and perirenal soft tissue. Immunofluorescence was negative for C3, IgG, IgM, IgA, and C1q. Pauci-immune (ANCA-associated) crescentic glomerulonephritis along with lymphocytic infiltration of interstitium due to CLL/SLL flare was diagnosed. She was treated with pulse IV methyl prednisolone (1000 mg/day) for 3 days followed by oral prednisolone of 1 mg/kg/day which tapered after 1 month and IV cyclophosphamide 500 mg/m 2 pulse fortnightly. She had persistent dialysis dependent renal failure even at the end of 3 months. Six months later, she died of fulminant bacterial sepsis.
The renal manifestation of CLL is varied. Only <2% of CLL patients have detectable ANCA titers. [2] Nephrotic syndrome occurs in 1%-2% and is considered to be a true paraneoplastic syndrome secondary to membranoproliferative glomerulonephritis (33.7%) and membranous nephropathy (19%). [3] Cryoglobulin secreting B-cell clone is identified in 50% of CLL with renal involvement. Minimal change, focal segmental sclerosis, focal glomerulonephritis, amyloidosis, immunotactoid, and crescentic glomerulonephritis have also been described.
Our patient presented with pauci-immune ANCA (c-ANCA)-associated crescentic glomerulonephritis with CLL/SLL. Till date, only a few such case reports have been published. Among five cases reported in literature [ Table 1 ], four had p-ANCA positive and one had c-ANCA positive. Crescentic glomerulonephritis was seen in four patients. The time duration between the occurrence of ANCA-mediated crescentic glomerulonephritis and CLL is varied. The aim of management is usually to achieve remission of CLL. Most of the reported cases of ANCA vasculitis in CLL had poor outcome. [4, 5] Overall patient survival was influenced by CLL and its complications rather than renal disease.
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